SARS-CoV-2 Omicron escapes mRNA vaccine booster-induced antibody neutralisation in patients with autoimmune rheumatic diseases: an observational cohort …

WJ Kim, SH Choi, JY Park, JS Song… - Annals of the …, 2022 - ard.bmj.com
Objectives This study investigates whether COVID-19 vaccines can elicit cross-reactive
antibody responses against the Omicron variant in patients with autoimmune rheumatic …

A Mendelian randomization study of genetic predisposition to autoimmune diseases and COVID-19

S Li, S Yuan, CM Schooling, SC Larsson - Scientific Reports, 2022 - nature.com
Autoimmune diseases and coronavirus disease 2019 (COVID-19) share many similarities.
Concerns have arisen that autoimmune diseases may increase the susceptibility and …

Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases

A Antonelli, P Fallahi, G Elia, F Ragusa… - The Lancet …, 2021 - thelancet.com
Comment e676 www. thelancet. com/rheumatology Vol 3 October 2021 8375 [90· 1%]
women and 893 [9· 6%] men) between April 3 and May 8, 2020. The most frequent …

Perspectives on subcutaneous infliximab for rheumatic diseases and inflammatory bowel disease: before, during, and after the COVID-19 era

S Schreiber, S Ben-Horin, R Alten, R Westhovens… - Advances in …, 2022 - Springer
Abstract The coronavirus disease 2019 (COVID-19) pandemic has prompted significant
changes in patient care in rheumatology and gastroenterology, with clinical guidance issued …

The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study

B Sozeri, K Ulu, U Kaya-Akça, F Haslak… - Rheumatology …, 2022 - Springer
The effects of biological disease-modifying antirheumatic drugs (bDMARDs) in the clinical
course of COVID-19 on children with underlying rheumatologic diseases have not been fully …

The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet's syndrome

G Ozcifci, T Aydin, Z Atli, II Balkan, F Tabak… - Rheumatology …, 2022 - Springer
Initial case series of small number of patients at the beginning of the pandemic reported a
rather guarded prognosis for Behçet's syndrome (BS) patients infected with SARS-CoV-2. In …

Single‐cell multi‐omics analysis of COVID‐19 patients with pre‐existing autoimmune diseases shows aberrant immune responses to infection

A Barmada, LF Handfield… - European Journal of …, 2024 - Wiley Online Library
In COVID‐19, hyperinflammatory and dysregulated immune responses contribute to
severity. Patients with pre‐existing autoimmune conditions can therefore be at increased risk …

Preexisting autoimmunity is associated with increased severity of coronavirus disease 2019: A retrospective cohort study using data from the national COVID cohort …

AS Yadaw, DK Sahner, H Sidky, B Afzali… - Clinical Infectious …, 2023 - academic.oup.com
Background Identifying individuals with a higher risk of developing severe coronavirus
disease 2019 (COVID-19) outcomes will inform targeted and more intensive clinical …

Covid-19 and rheumatic autoimmune systemic diseases: role of pre-existing lung involvement and ongoing treatments

C Ferri, D Giuggioli, V Raimondo… - Current …, 2021 - ingentaconnect.com
Background: The Covid-19 pandemic may have a deleterious impact on patients with
autoimmune systemic diseases (ASD) due to their deep immune-system alterations …

Understanding COVID‐19 Risk in Patients With Immune‐Mediated Inflammatory Diseases: A Population‐Based Analysis of SARS–CoV‐2 Testing

L Eder, R Croxford, AM Drucker, A Mendel… - Arthritis care & …, 2023 - Wiley Online Library
Objective To investigate the incidence of and factors associated with SARS–CoV‐2 testing
and infection in immune‐mediated inflammatory disease (IMID) patients versus matched …